col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


23 Results       Page 1

 [1] 
Springer-Verlag: Angiogenesis
  original article Date Title Authors   All Authors
1 [GO] 2025―Dec―07 Hydroxychloroquine does not affect endotheliopathy or coagulopathy biomarkers in COVID-19: longitudinal results from the DisCoVeRy randomized trial Clément R. Massonnaud, Maya Hites, Nathan Peiffer-Smadja, Jeanne Rancic, Yazdan Yazdanpanah, Sophie Luneau, et al. (+8)
2 [GO] 2024―Dec―20 Circulating endothelial cells: a key biomarker of persistent fatigue after hospitalization for COVID-19 David M. Smadja, Sven Günther, Pauline Cavagna, Bertrand Renaud, Dominique Salmon, Bertrand Hermann, et al. (+4)
3 [GO] 2024―Apr―24 Systemic glucocorticoids link to long-term microvascular injury in COVID-19 Qian Yang, Cai Yun Xia, Ying Cai, Yan Fang Zhang, Dao Ting Li, Shu Qi Wu, Peng Hu
4 [GO] 2024―Apr―10 Interleukin-6 drives endothelial glycocalyx damage in COVID-19 and bacterial sepsis Carolin Christina Drost, Alexandros Rovas, Irina Osiaevi, Klaus Schughart, Alexander Lukasz, Wolfgang A. Linke, et al. (+2)
5 [GO] 2024―Mar―26 Connective tissue disorders in COVID-19: Reply to “People with a connective tissue disorder may be especially vulnerable to the endothelial damage that characterizes long COVID due to the fragility of their vasculature and slow wound healing” Xiaoming Wu, Valerie A. Novakovic, Jialan Shi
6 [GO] 2024―Feb―06 People with a connective tissue disorder may be especially vulnerable to the endothelial damage that characterizes long COVID due to the fragility of their vasculature and slow wound healing Jeffrey Lubell
7 [GO] 2023―Dec―09 Circulating Von Willebrand factor: a consistent biomarker predicting in-hospital mortality across different waves of the COVID-19 pandemic David M. Smadja, Anne-Sophie Jannot, Aurélien Philippe, Estelle Lu, Jeanne Rancic, Olivier Sanchez, et al. (+3)
8 [GO] 2023―Sep―02 Reply to “Embracing imatinib: a novel approach to safeguarding the endothelial barrier in patients with COVID-19” Xiaoming Wu, Jialan Shi
9 [GO] 2023―Aug―02 Embracing Imatinib: a novel approach to safeguarding the endothelial barrier in patients with COVID-19 Chia Siang Kow, Dinesh Sangarran Ramachandram, Syed Shahzad Hasan
10 [GO] 2023―Aug―01 VEGF-A plasma levels are associated with impaired DLCO and radiological sequelae in long COVID patients Aurélien Philippe, Sven Günther, Jeanne Rancic, Pauline Cavagna, Bertrand Renaud, Nicolas Gendron, et al. (+9)
11 [GO] 2023―Apr―27 Damage to endothelial barriers and its contribution to long COVID Xiaoming Wu, Mengqi Xiang, Haijiao Jing, Chengyue Wang, Valerie A. Novakovic, Jialan Shi
12 [GO] 2022―Nov―12 Inflammation and vascular remodeling in COVID-19 hearts Christopher Werlein, Maximilian Ackermann, Helge Stark, Harshit R. Shah, Alexandar Tzankov, Jasmin Dinonne Haslbauer, et al. (+23)
13 [GO] 2022―Aug―11 Persistent capillary rarefication in long COVID syndrome Irina Osiaevi, Arik Schulze, Georg Evers, Kimon Harmening, Hans Vink, Philipp Kümpers, et al. (+2)
14 [GO] 2022―Jun―20 Microvascular and proteomic signatures overlap in COVID-19 and bacterial sepsis: the MICROCODE study Alexandros Rovas, Konrad Buscher, Irina Osiaevi, Carolin Christina Drost, Jan Sackarnd, Phil-Robin Tepasse, et al. (+11)
15 [GO] 2021―Oct―29 Interferon-alpha or -beta facilitates SARS-CoV-2 pulmonary vascular infection by inducing ACE2 Timothy Klouda, Yuan Hao, Hyunbum Kim, Jiwon Kim, Judith Olejnik, Adam J. Hume, et al. (+11)
16 [GO] 2021―Jun―28 COVID-19 is a systemic vascular hemopathy: insight for mechanistic and clinical aspects David M. Smadja, Steven J. Mentzer, Michaela Fontenay, Mike A. Laffan, Maximilian Ackermann, Julie Helms, et al. (+18)
17 [GO] 2021―Jun―08 Letter in response to: circulating von Willebrand factor and high molecular weight multimers as markers of endothelial injury predict COVID-19 in-hospital mortality P. Bhogal, G. Paul, G. Collins, O. Jaffer
18 [GO] 2021―May―11 Von Willebrand factor collagen-binding capacity predicts in-hospital mortality in COVID-19 patients: insight from VWF/ADAMTS13 ratio imbalance Aurélien Philippe, Nicolas Gendron, Olivier Bory, Agathe Beauvais, Tristan Mirault, Benjamin Planquette, et al. (+4)
19 [GO] 2021―Mar―23 Circulating level of Angiopoietin-2 is associated with acute kidney injury in coronavirus disease 2019 (COVID-19) Brandon Michael Henry, Maria Helena Santos de Oliveira, Isaac Cheruiyot, Justin L. Benoit, David S. Cooper, Giuseppe Lippi, et al. (+2)
20 [GO] 2021―Jan―15 Circulating Von Willebrand factor and high molecular weight multimers as markers of endothelial injury predict COVID-19 in-hospital mortality Aurélien Philippe, Richard Chocron, Nicolas Gendron, Olivier Bory, Agathe Beauvais, Nicolas Peron, et al. (+25)
21 [GO] 2020―Oct―14 Angiogenesis, hereditary hemorrhagic telangiectasia and COVID-19 Antoni Riera-Mestre, Adriana Iriarte, Manuela Moreno, Raul del Castillo, Daniel López-Wolf
22 [GO] 2020―Oct―14 Microvascular dysfunction in COVID-19: the MYSTIC study Alexandros Rovas, Irina Osiaevi, Konrad Buscher, Jan Sackarnd, Phil-Robin Tepasse, Manfred Fobker, et al. (+8)
23 [GO] 2020―May―27 Angiopoietin-2 as a marker of endothelial activation is a good predictor factor for intensive care unit admission of COVID-19 patients David M. Smadja, Coralie L. Guerin, Richard Chocron, Nader Yatim, Jeremy Boussier, Nicolas Gendron, et al. (+17)
 [1] 

23 Results       Page 1


[de][en]

Last change 2025―Jul―29 14:55:09 UTC

© Daten-Quadrat 2022       Done in 0.003 sec